Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
VH-Fc ab8 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021 2 0
IgG1 ab1 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021 2 0
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 2 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Ad26.COV2.S Emergency use authorization Experimental Vaccine Apr/28/2021 7 0
Trichostatin A Potential treatment - theoretical effect Natural product Antiviral Apr/10/2021 1 0
6-beta-D-Glucopyranosyl-4',5-dihydroxy-7-methoxyflavone Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 1 0